GI
Grifols, S.A.
GIFOF · OTC
$8.85 +0.00% (+$0.00)
Market Cap 7.58B €
P/E Ratio 16.77x
Div. Yield 3.18%
ROE 8.43%
Bulios Fair Price
$10.91
23.3% upside
Current Price
$8.85
Undervalued Fair Value Overvalued
According to Bulios Fair Price, GIFOF is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Strong
7/9Valuation
89 /100
Cheap PEG 0.12x
P/E 16.77x
P/B 1.37x
Growth
66 /100
Stable Book val. growth 4.91%
EPS growth 23.93%
Rev. growth 7.44%
Profitability
64 /100
Moderate Op. margin 16.66%
Gross margin 37.23%
FCF margin 10.32%
Quality
31 /100
Poor ROA 2.25%
ROIC 5.48%
Asset turnover 0.37x
Debt
34 /100
Moderate Int. coverage 2.44x
Debt/Equity 1.54x
Net debt/EBITDA 4.95x
Stability
61 /100
Moderate EPS volatility 134.15%
Beta 1.19x
Profitable years 6
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about GIFOF
Online
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Jose Ignacio Abia Buenache
Employees
25,258
Headquarters
Barcelona
Upcoming events
10 NOV
Earnings
Upcoming earnings report